Cafepharma Today

July 3 2025 - Summit said to be in talks with Astra to license potential rival for Merck’s Keytruda
Summit said to be in talks with Astra to license potential rival for Merck’s Keytruda
AstraZeneca board
Intuitive Surgical’s da Vinci 5 robot wins CE mark
Intuitive Surgical board
Novartis drug flunks phase 3 test in giant cell arteritis
Novartis board
Bluebird go-private deal signals the ‘PE-ization of pharma’
General Pharma Discussion board
*please scroll down for all the latest news*

Check open job listings in your area
Click here to get the top four headlines in your inbox Mon-Fri (free)

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Lawmakers urge FDA to investigate clinical trials run in tandem with China's military
Fierce Pharma
Tuesday, August 20, 2024 - 10:06pm
tags:
FDA, China, clinical trials, Biosecure Act
Teva faces fresh Copaxone kickbacks case from Medicare providers as it defends against DOJ claims
Fierce Pharma
Tuesday, August 20, 2024 - 10:04pm
tags:
Teva Pharmaceutical, Copaxone, Medicare, kickbacks, legal, DOJ
Medtronic posts Q1 earnings beat, raises full-year outlook
Yahoo Finance
Tuesday, August 20, 2024 - 10:02pm
tags:
Medtronic, Medtech, earnings
FDA declines to approve Regeneron's blood cancer therapy
Reuters
Tuesday, August 20, 2024 - 9:59pm
tags:
Regeneron, FDA, linvoseltamab, Multiple Myeloma
Lilly’s tirzepatide cuts diabetes risk, study data show
BioPharma Dive
Tuesday, August 20, 2024 - 11:54am
tags:
Eli Lilly, tirzepatide, Mounjaro, Zepbound, type 2 diabetes, diabetes, clinical trials
Lundbeck ups guidance on higher expectations for Rexulti, Vyepti
First Word Pharma
Tuesday, August 20, 2024 - 11:50am
tags:
Lundbeck, earnings, Rexulti, Vyepti
Incyte and Syndax's immunotherapy for transplant complications receives FDA approval
Biopharma Reporter
Tuesday, August 20, 2024 - 11:49am
tags:
Incyte, Syndax, immunotherapy, Niktimvo, graft vs host disease
Talus Bio tacks on $11M to target hard-to-reach transcription factors
Fierce Biotech
Tuesday, August 20, 2024 - 11:39am
tags:
Talus Bioscience, funding, transcription factors, cancer, drug discovery
Targeting AZ's Tagrisso, Johnson & Johnson's Rybrevant combo wins key FDA nod in first-line lung cancer
Fierce Pharma
Tuesday, August 20, 2024 - 11:36am
tags:
JNJ, AstraZeneca, FDA, non-small cell lung cancer, Rybrevant, Lazcluze, Tagrisso
After Europe deal, Organon pays $22.5M to expand Emgality marketing pact with Lilly
Fierce Pharma
Tuesday, August 20, 2024 - 11:34am
tags:
Organon, Europe, Eli Lilly, Emgality, Rayvow, migraines
Does Ozempic increase the risk of suicidal thoughts? A new study muddles the picture
Stat
Tuesday, August 20, 2024 - 11:11am
tags:
Novo Nordisk, Ozempic, Wegovy, suicidal ideation
J&J to buy medical device maker V-Wave for up to $1.7 bln
Reuters
Tuesday, August 20, 2024 - 11:08am
tags:
JNJ, M&A, Medtech, V-Wav e
GlycoNex reports positive results for denosumab biosimilar Phase I trial
Clinical Trials Arena
Tuesday, August 20, 2024 - 10:31am
tags:
GlycoNex, clinical trials, biosimilars, denosumab, osteoporosis
Roche says it is working to enhance lab testing capacity for mpox worldwide
Reuters
Tuesday, August 20, 2024 - 10:29am
tags:
Roche, diagnostics, mpox
23andMe inches closes to cancer immunotherapy, guided by its genetic database
Pharma Voice
Tuesday, August 20, 2024 - 10:28am
tags:
23andMe, diagnostics, Medtech, cancer immunotherapy, drug discovery
Adcendo licenses Multitude anti-TF ADC in $1bn+ deal
Pharmaphorum
Tuesday, August 20, 2024 - 10:27am
tags:
Adcendo, antibody-drug conjugates, Multitude Therapeutics, cancer, anti-TF
Impact of federal negotiation of prescription drug prices
Brookings
Monday, August 19, 2024 - 7:26pm
tags:
Medicare, drug pricing, Inflation Reduction Act
Edwards Makes It Rain with Spinoff Cash
Medical Devices and Diagnostics Industry
Monday, August 19, 2024 - 7:22pm
tags:
Edwards Lifesciences, spinoffs, M&A, Medtech
Emergent to donate 50,000 vaccine doses to address mpox outbreak in Africa
Reuters
Monday, August 19, 2024 - 7:18pm
tags:
Emergent BioSolutions, mpox, vaccines, philanthropy
Amid sales slump, Avantor sells off its clinical services business for $650m
Clinical Trials Arena
Monday, August 19, 2024 - 7:16pm
tags:
Avantor, M&A, clinical trials, clinical services

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Assays Are Always Welcome
In the Pipeline
Down In the Reaction Details
In the Pipeline
The "Healthy Vaccinee" Effect
In the Pipeline
The Continuing Crisis, Part XVI: Get the Hell Out of Your Building
In the Pipeline
Tiny Crystals from Small Extracts
In the Pipeline
Hexanitrogen
In the Pipeline
Stir Bars Can't Be Ignored
In the Pipeline
AI Effects on Drug Patents
In the Pipeline
Mirror Morphine
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.